Related Experiment Video
Updated: Jun 17, 2026
23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
19.1K
Digital Health Interventions to Enhance Tuberculosis Treatment Adherence: Scoping Review
Sol Lee1, Vasuki Rajaguru2, Joon Sang Baek3
1Yonsei University Health System, Yonsei University, Seoul, Republic of Korea.
JMIR Mhealth and Uhealth
|December 6, 2023
Summary
Digital health interventions (DHIs) show promise for tuberculosis (TB) self-management. Further development is needed to improve TB treatment adherence through enhanced bidirectional communication strategies.
Area of Science:
- Digital health technologies
- Health informatics
- Public health
Background:
- Digital health technologies are integral to modern healthcare, particularly for managing chronic and infectious diseases like tuberculosis (TB).
- These technologies encompass computing platforms, software, and sensors designed for patient care and disease management.
- Their application in managing tuberculosis (TB) is a growing area of interest.
Purpose of the Study:
- To conduct a comprehensive literature review on digital health interventions (DHIs) for improving TB treatment adherence.
- To identify key strategies for the successful adoption of DHIs in TB management.
- To assess the current evidence on the effectiveness of digital health in TB care.
Main Methods:
- A systematic literature search was performed across major databases (PubMed, Cochrane Library, Embase, Scopus) for studies published between January 2012 and March 2022.
- Included studies focused on web-based or mobile interventions, medication adherence, and digital health technologies for TB treatment.
- The review encompassed randomized controlled trials and studies on mobile health and ubiquitous health technology.
Main Results:
- Twenty-seven relevant studies were identified and categorized by intervention type and outcomes.
- SMS text messaging (30%), medicine reminders (22%), and web-based direct observation therapy (33%) were prominent DHIs.
- Digital health significantly improved disease management for patients and healthcare providers, though bidirectional communication interventions were underrepresented.
Conclusions:
- Digital health interventions (DHIs) demonstrate potential for enhancing tuberculosis (TB) self-management.
- Evidence on the impact of digital technologies on TB treatment adherence is still developing.
- There is a critical need to develop robust communication systems to encourage patient engagement and self-management in TB treatment.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.